Anyone who follows me knows that I’ve been questioning whether digital therapeutics are real and more importantly whether the people building and trying to sell them are simply trying to replicate the American drug pricing model–patent, protect, prescribe & price gouge. So who better to have this conversation with than the person in charge of explaining and selling the notion of digital therapeutics to the world? Megan Coder is Executive Director of the Digital Therapeutics Alliance. She graciously and bravely agreed to talk to me. Who won the argument? You’ll have to watch to decide, but I found our discussion to be a lot of fun and very interesting and I hope you will too – Matthew Holt
The transcript is below
Hi, it’s Matthew Holt with a THCB spotlight. I’m here with Megan Coder. Megan is the executive director of the Digital Therapeutics Alliance. And we’re here to talk about this thing called digital therapeutics, as to what they are, what the alliance does and whether they really exist and how we should treat them. Megan, thanks for coming on. I know we’ve done a little bit of sparring online and in-person, but I’ve never interviewed you. So I’m looking forward to this. So how are you doing?
Good. It’s more fun to spar in-person, but I miss the in-person aspect.
I mean, we’re all hoping to get back of that pretty soon. But I’m in my fifties and they’re not so far away in California from giving us old people the shots and then hopefully we’ll be back to normal at some point. Anyway, for those people who don’t know, just tell people what the Digital Therapeutics Alliance is. And then we’ll dive into a bit about what digital therapeutics are, but tell us about the organization that you